Simultaneous Population PKPD Analysis of Belantamab Mafodotin, Soluble BCMA, and Serum M-Protein in Subjects With Relapsed/Refractory Multiple Myeloma Poster 复发/难治性多发性骨髓瘤患者 Belantamab Mafodotin、可溶性B细胞成熟抗原(BCMA)和血清 M-蛋白的群体药代动力学-药效学(PKPD)同步分析 Certara2024 年 11 月 22 日
A Pharmacokinetic Analysis of Drug Concentration Using a Novel Deep Learning Model Poster 利用新型深度学习模型进行药物浓度的药代动力学分析 Certara2024 年 11 月 22 日
Model-Informed Drug Development Framework for the Development and Dose Optimization of Targeted Radiation Therapies Poster 用于开发和优化靶向辐射疗法剂量的模型引导的药物开发框架 Certara2024 年 11 月 22 日
Oncology MIDD Simulator, A User-Friendly Application for Overall Survival Forecasting in Early Oncology Trials Poster Oncology MIDD Simulator — 用于早期肿瘤学试验总生存期预测的用户友好型应用程序 Certara2024 年 11 月 22 日
Population pharmacokinetic modeling of niraparib to assess different absorption models Poster 尼拉帕利(Niraparib)群体药代动力学建模以评估不同吸收模型 Certara2024 年 11 月 22 日
A Sequential Population Pharmacokinetic Model of Zilovertamab Vedotin in Patients with Hematologic Malignancies Extrapolated to the Pediatric Population Publication Zilovertamab Vedotin 在血液恶性肿瘤患者中的序贯群体药代动力学模型推断至儿童群体 Certara2024 年 11 月 7 日
Mathematical Models can Assist in Broadening use of Immuno-oncology Drugs to Treat Autoimmunity Blog 数学模型有助于扩大免疫肿瘤药物治疗自身免疫疾病的应用范围 2024 年 10 月 31 日 The level of immune activation is enormously influential for the progression of…Certara2024 年 10 月 31 日
RAPS Sponsored Webcast: Optimizing Pediatric Oncology Drug Development: A Comprehensive Overview On-Demand Webinar RAPS 赞助的网络广播:优化儿科肿瘤药物研发:全面综述 Developing safe and effective oncology medications for children presents unique challenges due to ethical considerations…Certara2024 年 10 月 17 日
Quantitative Systems Pharmacology (QSP) Enabled First-in-Human Study in Oncology On-Demand Webinar 基于定量系统药理学(QSP)的肿瘤学首次人体试验研究 Certara2024 年 9 月 16 日
Using Quantitative Systems Pharmacology (QSP) Modeling for Oncology Dose Optimization On-Demand Webinar 应用定量系统药理学(QSP)建模优化肿瘤学剂量 The FDA’s Project Optimus initiative aims to reform dose optimization and selection for oncology therapies…Certara2024 年 8 月 19 日